Drug Discovery Department, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.
Trends Genet. 2013 Jul;29(7):394-402. doi: 10.1016/j.tig.2013.02.003. Epub 2013 Mar 26.
The cell cycle requires cells to duplicate their chromatin, DNA, and histones, while retaining a subset of epigenetic marks, in a highly coordinated manner. The WEE1 kinase was identified as an important regulator during S phase, preventing entry into mitosis until DNA replication has been completed. Interestingly, WEE1 has also emerged as a key player in regulating histone synthesis. It phosphorylates histone H2B at tyrosine 37 in the nucleosomes found upstream of the histone gene cluster, and this suppresses histone transcription in late S phase. These observations highlight a dual role for WEE1 as both a mitotic gatekeeper and a surveyor of chromatin synthesis, providing a direct link between epigenetics and cell-cycle progression. Importantly, this link has implications for the design of novel epigenetic inhibitors targeting cancers that display elevated expression of this kinase.
细胞周期需要细胞以高度协调的方式复制染色质、DNA 和组蛋白,同时保留一小部分表观遗传标记。WEE1 激酶被鉴定为 S 期的重要调节因子,防止细胞进入有丝分裂,直到 DNA 复制完成。有趣的是,WEE1 也已成为调节组蛋白合成的关键因素。它在核小体上游的组蛋白基因簇中磷酸化组蛋白 H2B 的酪氨酸 37,从而抑制晚期 S 期的组蛋白转录。这些观察结果突出了 WEE1 的双重作用,既是有丝分裂的守门员,也是染色质合成的巡视员,为表观遗传学和细胞周期进程之间提供了直接联系。重要的是,这种联系对于设计针对表达这种激酶的癌症的新型表观遗传抑制剂具有重要意义。